1: Nakajima M, Kuroiwa Y, Yokoi T. Links
Interindividual differences in nicotine metabolism and genetic polymorphisms of human CYP2A6.
Drug Metab Rev. 2002 Nov;34(4):865-77.
PMID: 12487152 [PubMed - in process]
2: Makris TM, Davydov R, Denisov IG, Hoffman BM, Sligar SG. Links
Mechanistic enzymology of oxygen activation by the cytochromes P450.
Drug Metab Rev. 2002 Nov;34(4):691-708.
PMID: 12487147 [PubMed - in process]
3: Johnson K, Shah A, Jaw-Tsai S, Baxter J, Prakash C. Related Articles, Links
Metabolism, Pharmacokinetics, and Excretion of a Highly Selective N-Methyl-D-aspartate Receptor Antagonist, Traxoprodil, in Human Cytochrome P450 2D6 Extensive and Poor Metabolizers.
Drug Metab Dispos. 2003 Jan 1;31(1):76-87.
PMID: 12485956 [PubMed - as supplied by publisher]
4: Fan PW, Gu C, Marsh SA, Stevens JC. Related Articles, Links
Mechanism-Based Inactivation of Cytochrome P450 2B6 by a Novel Terminal Acetylene Inhibitor.
Drug Metab Dispos. 2003 Jan 1;31(1):28-36.
PMID: 12485950 [PubMed - as supplied by publisher]
5: Rooseboom M, Vermeulen NP, Durgut F, Commandeur JN. Related Articles, Links
Comparative Study on the Bioactivation Mechanisms and Cytotoxicity of Te-Phenyl-L-tellurocysteine, Se-Phenyl-L-selenocysteine, and S-Phenyl-L-cysteine.
Chem Res Toxicol. 2002 Dec;15(12):1610-8.
PMID: 12482244 [PubMed - in process]
Time used: 31 miliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005